[Antitubercular chemotherapy]
- PMID: 9496594
[Antitubercular chemotherapy]
Abstract
Treatment of tuberculosis has three major goals: healing the patient, preventing selection of resistant strains and control transmission of tuberculosis. A 6 month regimen consisting of isoniazid, rifampin with addition of pyrazinamide for 2 months is the preferred treatment for pulmonary and extra-pulmonary tuberculosis. If resistance to isoniazid is suspected, ethambutol should be added until drug susceptibility studies become available. This treatment is effective in both HIV infected and uniinfected persons. Treatment failure is mostly related to lack of patient adherence to the drug regimen and to multidrug-resistant tuberculosis. The treatment of multidrug-resistant tuberculosis requires second line drugs which are less effective and poorly tolerated. Prevention of resistant tuberculosis needs adequate treatment of each case of tuberculosis and improving of the patient compliance.
Similar articles
-
Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society.Monaldi Arch Chest Dis. 1994 Sep;49(4):327-45. Monaldi Arch Chest Dis. 1994. PMID: 8000420
-
Results of a 12-month regimen for drug-resistant pulmonary tuberculosis.Int J Tuberc Lung Dis. 2002 Dec;6(12):1102-9. Int J Tuberc Lung Dis. 2002. PMID: 12546119 Clinical Trial.
-
How drug resistance emerges as a result of poor compliance during short course chemotherapy for tuberculosis.Int J Tuberc Lung Dis. 1998 Jan;2(1):10-5. Int J Tuberc Lung Dis. 1998. PMID: 9562106
-
Drug-resistant tuberculosis: etiology, management and prevention.Semin Respir Infect. 1994 Jun;9(2):104-12. Semin Respir Infect. 1994. PMID: 7973169 Review.
-
Present status of chemotherapy for tuberculosis.Rev Infect Dis. 1989 Mar-Apr;11 Suppl 2:S347-52. doi: 10.1093/clinids/11.supplement_2.s347. Rev Infect Dis. 1989. PMID: 2652251 Review.